Castle Biosciences, Inc.CSTL stock score: 58/100

$33.41 · +0.07% · Scored Nov 19, 2026

Technical
55
Fundamental
59
News
51

The reading

Castle Biosciences (CSTL) scores 58 out of 100, which reads neutral, higher than 70% of Healthcare stocks and 71% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 59, technicals 55.

Among the fundamentals, Price Target at 100 and Revenue Growth (5-Year) at 100 score highest, while Earnings Growth (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 44 and contrarian oscillators 62.

News sentiment is neutral at 51; it is shown, not counted in the composite.

Since Aug 23, 2026 the composite has ranged from 50 to 60, and it is up 1 point over the period.

About Castle Biosciences

Castle Biosciences (CSTL) is a molecular diagnostics company that develops and performs tests to help doctors guide care for patients with skin cancers, gastrointestinal disease and other conditions. Its main test, DecisionDx-Melanoma, analyzes gene expression in a patient’s tumor to estimate the risk of recurrence or spread of cutaneous melanoma and the likelihood that a sentinel lymph node biopsy would find cancer. Its other core test, TissueCypher, assesses the risk that patients with Barrett’s esophagus will progress to esophageal cancer. The company also offers a test for uveal melanoma, a cancer of the eye, and tests that help classify suspicious pigmented skin lesions. Castle earns money from payments by Medicare, commercial insurers and patients for each test report, so coverage and reimbursement decisions shape its revenue.

Castle competes with other genomic testing laboratories, academic labs and standard clinical and pathology assessment, which doctors can use instead of its tests. Its edge rests on a large body of peer-reviewed clinical evidence, Medicare coverage for its core tests and a sales force with relationships among dermatologists and gastroenterologists. Investors who follow CSTL stock tend to watch test report volumes for DecisionDx-Melanoma and TissueCypher. Average reimbursement per test and Medicare coverage decisions are closely followed. Inclusion in clinical guidelines, regulatory plans for DecisionDx-Melanoma, development of new tests, cash and operating expenses are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward CSTL’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

59

Pulling it up

  • Price target score compares the current stock price to analyst consensus targets.

  • 5-year revenue growth analyzes long-term sales trajectory and consistency.

  • How the latest quarter's revenue compares with the average of the last four, plus a bonus for steady quarterly revenue.

Holding it back

38 weighted scorers; 1 had no data today and are left out rather than counted as zero.

Technical · daily

48

Pulling it up

  • Simple Moving Average (200-period) is the most widely followed long-term trend indicator.

  • Performance versus SPY compares the stock's returns to the S&P 500 index.

  • Exponential Moving Average (200-period) is a crucial long-term trend indicator that reacts faster than SMA-200.

Holding it back

  • Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.

  • TRIX is a triple-smoothed momentum oscillator.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
51

Technical score by timeframe

ChartScoreWeight
Hourly441
Daily483
Weekly612
Monthly632

Composite score, last 90 days

05010058Aug 23, 2026Nov 19, 2026Aug 23, 2026: 57Aug 24, 2026: 56Aug 25, 2026: 57Aug 26, 2026: 56Aug 27, 2026: 56Aug 28, 2026: 55Aug 29, 2026: 56Aug 30, 2026: 56Aug 31, 2026: 55Sep 1, 2026: 56Sep 2, 2026: 56Sep 4, 2026: 55Sep 5, 2026: 55Sep 6, 2026: 55Sep 7, 2026: 55Sep 8, 2026: 56Sep 9, 2026: 54Sep 10, 2026: 54Sep 11, 2026: 55Sep 12, 2026: 55Sep 13, 2026: 55Sep 14, 2026: 56Sep 15, 2026: 57Sep 16, 2026: 56Sep 17, 2026: 57Sep 18, 2026: 56Sep 19, 2026: 56Sep 20, 2026: 56Sep 21, 2026: 55Sep 22, 2026: 56Sep 23, 2026: 57Sep 24, 2026: 56Sep 25, 2026: 57Sep 26, 2026: 57Sep 27, 2026: 57Sep 28, 2026: 57Sep 29, 2026: 55Sep 30, 2026: 56Oct 1, 2026: 56Oct 2, 2026: 56Oct 3, 2026: 56Oct 4, 2026: 56Oct 5, 2026: 57Oct 6, 2026: 55Oct 7, 2026: 53Oct 8, 2026: 53Oct 9, 2026: 55Oct 10, 2026: 55Oct 11, 2026: 55Oct 12, 2026: 53Oct 13, 2026: 53Oct 14, 2026: 53Oct 15, 2026: 54Oct 16, 2026: 52Oct 17, 2026: 52Oct 18, 2026: 52Oct 19, 2026: 52Oct 20, 2026: 53Oct 21, 2026: 55Oct 22, 2026: 54Oct 23, 2026: 53Oct 24, 2026: 53Oct 25, 2026: 53Oct 26, 2026: 54Oct 27, 2026: 56Oct 28, 2026: 56Oct 29, 2026: 57Oct 30, 2026: 56Nov 1, 2026: 56Nov 2, 2026: 55Nov 3, 2026: 54Nov 4, 2026: 54Nov 5, 2026: 52Nov 6, 2026: 50Nov 7, 2026: 50Nov 10, 2026: 52Nov 11, 2026: 53Nov 12, 2026: 60Nov 13, 2026: 59Nov 14, 2026: 58Nov 15, 2026: 58Nov 16, 2026: 57Nov 17, 2026: 58Nov 18, 2026: 58Nov 19, 2026: 58
Show the daily numbers
DateComposite
Nov 19, 202658
Nov 18, 202658
Nov 17, 202658
Nov 16, 202657
Nov 15, 202658
Nov 14, 202658
Nov 13, 202659
Nov 12, 202660
Nov 11, 202653
Nov 10, 202652
Nov 7, 202650
Nov 6, 202650
Nov 5, 202652
Nov 4, 202654
Nov 3, 202654
Nov 2, 202655
Nov 1, 202656
Oct 30, 202656
Oct 29, 202657
Oct 28, 202656
Oct 27, 202656
Oct 26, 202654
Oct 25, 202653
Oct 24, 202653
Oct 23, 202653
Oct 22, 202654
Oct 21, 202655
Oct 20, 202653
Oct 19, 202652
Oct 18, 202652
Oct 17, 202652
Oct 16, 202652
Oct 15, 202654
Oct 14, 202653
Oct 13, 202653
Oct 12, 202653
Oct 11, 202655
Oct 10, 202655
Oct 9, 202655
Oct 8, 202653
Oct 7, 202653
Oct 6, 202655
Oct 5, 202657
Oct 4, 202656
Oct 3, 202656
Oct 2, 202656
Oct 1, 202656
Sep 30, 202656
Sep 29, 202655
Sep 28, 202657
Sep 27, 202657
Sep 26, 202657
Sep 25, 202657
Sep 24, 202656
Sep 23, 202657
Sep 22, 202656
Sep 21, 202655
Sep 20, 202656
Sep 19, 202656
Sep 18, 202656
Sep 17, 202657
Sep 16, 202656
Sep 15, 202657
Sep 14, 202656
Sep 13, 202655
Sep 12, 202655
Sep 11, 202655
Sep 10, 202654
Sep 9, 202654
Sep 8, 202656
Sep 7, 202655
Sep 6, 202655
Sep 5, 202655
Sep 4, 202655
Sep 2, 202656
Sep 1, 202656
Aug 31, 202655
Aug 30, 202656
Aug 29, 202656
Aug 28, 202655
Aug 27, 202656
Aug 26, 202656
Aug 25, 202657
Aug 24, 202656
Aug 23, 202657

Key facts

Market cap
$1.0B
Sector
Healthcare
Industry
Diagnostics & Research
Beta
0.95
Risk grade (1–10)
6
Next earnings
Nov 5, 2026

Questions

What is CSTL's stock rating today?

CSTL scores 58/100 (Neutral) as of Nov 19, 2026: technical 55, fundamental 59, and news sentiment 51, which is shown but not counted. Scores are recomputed every night.

What does Castle Biosciences do?

Castle Biosciences (CSTL) is a molecular diagnostics company that develops and performs tests to help doctors guide care for patients with skin cancers, gastrointestinal disease and other conditions. Its main test, DecisionDx-Melanoma, analyzes gene expression in a patient’s tumor to estimate the risk of recurrence or spread of cutaneous melanoma and the likelihood that a sentinel lymph node biopsy would find cancer.

Is CSTL stock a buy?

The score is not a buy or sell recommendation. A 58 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the CSTL score calculated?

100 weighted scorers feed it today: 38 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 4 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

CSTL stock score

HTML

<a href="https://stocksscores.com/stocks/cstl/"><img src="https://stocksscores.com/stocks/cstl/badge.svg" alt="CSTL stock score" height="20"></a>

Markdown

[![CSTL stock score](https://stocksscores.com/stocks/cstl/badge.svg)](https://stocksscores.com/stocks/cstl/)